Compare STHO & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STHO | CBUS |
|---|---|---|
| Founded | 2022 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Agricultural Chemicals |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.0M | 121.1M |
| IPO Year | 2022 | 2017 |
| Metric | STHO | CBUS |
|---|---|---|
| Price | $8.91 | $1.43 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 19.4K | ★ 458.0K |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 24.73 | ★ 74.33 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $110,143,000.00 | $3,639,000.00 |
| Revenue This Year | N/A | $112.72 |
| Revenue Next Year | N/A | $83.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.06 | $1.09 |
| 52 Week High | $9.24 | $4.19 |
| Indicator | STHO | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 59.03 | 40.27 |
| Support Level | $7.26 | $1.21 |
| Resistance Level | $9.16 | $1.54 |
| Average True Range (ATR) | 0.22 | 0.12 |
| MACD | 0.04 | 0.06 |
| Stochastic Oscillator | 68.57 | 42.47 |
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties, and land and development properties.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.